Cite
HARVARD Citation
DeMartinis, N. et al. (2019). A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia. Journal of clinical psychopharmacology. 39 (4), p. . [Online].